secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zapata Quantum, Inc. (ZPTA)
CIK:        0001843714
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001079973-26-000531
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zapata Quantum completes oversubscribed $15M financing led by Triatomic Capital
-------------------------------------------------------------------------------

- $15M oversubscribed round led by Triatomic Capital; other strategic investors participated.
- Financing marks final milestone of year-long restructuring; capital to scale platform and team.
- Funds to be used to expand science, engineering, product, and commercial functions.
- Company highlights quantum-enabled drug discovery research named Nature Biotechnology cover paper in Dec 2025.
- Zapata focuses on hardware-agnostic quantum software, closing gap from experimentation to production.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1843714/000107997326000531/0001079973-26-000531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1843714/000107997326000531/zapata_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-000531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer